Cargando…

The Effects of the ManageHF4Life Mobile App on Patients With Chronic Heart Failure: Randomized Controlled Trial

BACKGROUND: The successful management of heart failure (HF) involves guideline-based medical therapy as well as self-management behavior. As a result, the management of HF is moving toward a proactive real-time technological model of assisting patients with monitoring and self-management. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorsch, Michael P, Farris, Karen B, Rowell, Brigid E, Hummel, Scott L, Koelling, Todd M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693200/ https://www.ncbi.nlm.nih.gov/pubmed/34878990 http://dx.doi.org/10.2196/26185

Ejemplares similares

A Novel Just-in-Time Contextual Mobile App Intervention to Reduce Sodium Intake in Hypertension: Protocol and Rationale for a Randomized Controlled Trial (LowSalt4Life Trial)
por: Dorsch, Michael P, et al.
Publicado: (2018)

The AppCare-HF randomized clinical trial: a feasibility study of a novel self-care support mobile app for individuals with chronic heart failure
por: Yokota, Takashi, et al.
Publicado: (2023)

Effects of a Novel Contextual Just-In-Time Mobile App Intervention (LowSalt4Life) on Sodium Intake in Adults With Hypertension: Pilot Randomized Controlled Trial
por: Dorsch, Michael P, et al.
Publicado: (2020)

Heart Failure-Smart Life: a randomized controlled trial of a mobile app for self-management in patients with heart failure
por: Choi, Eui-Young, et al.
Publicado: (2023)

Hyponatremia, Cognitive Function, and Mobility in an Outpatient Heart Failure Population
por: Albabtain, Monirah, et al.
Publicado: (2016)

Geographic variations in the PARADIGM-HF heart failure trial
por: Kristensen, Søren Lund, et al.
Publicado: (2016)

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
por: Wijkman, Magnus O., et al.
Publicado: (2022)

The Need for Fiber Addition in Symptomatic Heart Failure (FEAST-HF): A Randomized Controlled Pilot Trial
por: Colin-Ramirez, Eloisa, et al.
Publicado: (2023)

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2021)

Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C)
por: Chow, Benjamin JW, et al.
Publicado: (2013)

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
por: McMurray, John J V, et al.
Publicado: (2020)

Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?
por: Correia, Luis Cláudio Lemos, et al.
Publicado: (2016)

The Heart Failure Optimization Study (HF-OPT): rationale and design
por: Sanchez, R., et al.
Publicado: (2023)

Routine versus selective cardiac magnetic resonance in non-ischemic heart failure – OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B)
por: Paterson, Ian, et al.
Publicado: (2013)

Quality of life in heart failure patients undergoing hybrid comprehensive telerehabilitation versus usual care – results of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial
por: Piotrowicz, Ewa, et al.
Publicado: (2020)

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
por: Docherty, Kieran F, et al.
Publicado: (2020)

Decrease in the 30-day heart failure (HF) Rehospitalization Rate after the implementation of a HF managed protocol
por: Correa, AG, et al.
Publicado: (2009)

Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial
por: O’Meara, Eileen, et al.
Publicado: (2013)

The real-life data of hospitalized patients with heart failure: On behalf of the Journey HF-TR study investigators
por: Sinan, Ümit Yaşar, et al.
Publicado: (2019)

Would You Prescribe Mobile Health Apps for Heart Failure Self-care? An Integrated Review of Commercially Available Mobile Technology for Heart Failure Patients
por: Mortara, Andrea, et al.
Publicado: (2020)

A Patient-Oriented App (ThessHF) to Improve Self-Care Quality in Heart Failure: From Evidence-Based Design to Pilot Study
por: Bakogiannis, Constantinos, et al.
Publicado: (2021)

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) trial
por: Keene, Daniel, et al.
Publicado: (2018)

Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
por: Jensen, Jesper, et al.
Publicado: (2019)

PRIME‐HF: Novel Exercise for Older Patients with Heart Failure. A Pilot Randomized Controlled Study
por: Giuliano, Catherine, et al.
Publicado: (2020)

Self-care Management Intervention in Heart Failure (SMART-HF): A Multicenter Randomized Controlled Trial
por: Sahlin, Daniel, et al.
Publicado: (2022)

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
por: Spertus, John A., et al.
Publicado: (2022)

Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HF
por: Rubattu, Speranza, et al.
Publicado: (2017)

Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial
por: Störk, Stefan, et al.
Publicado: (2022)

Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2022)

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study
por: Domingo, Mar, et al.
Publicado: (2021)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF)
por: Sin, Phyllis, et al.
Publicado: (2022)

The COVID-19 pandemic and heart failure: lessons from GUIDE-HF( )
por: Cowie, Martin R, et al.
Publicado: (2022)

Perils and Pitfalls With Associations in Heart Failure, Particularly in HF-pEF
por: Carson, Peter E.
Publicado: (2023)

Atrial Fibrillation in Heart Failure: Epidemiology, Quality of Life and Clinical Characteristics in the Iron Deficiency and ANaemia in Heart Failure (IDAN-HF) Study in Ogbomoso, Nigeria
por: Akintunde, Adeseye A, et al.
Publicado: (2023)

Effect of a Smartphone-Based App on the Quality of Life of Patients With Heart Failure: Randomized Controlled Trial
por: Davoudi, Mahboube, et al.
Publicado: (2020)

Mobile Phone Apps to Support Heart Failure Self-Care Management: Integrative Review
por: Athilingam, Ponrathi, et al.
Publicado: (2018)

The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure
por: Poon, Stephanie, et al.
Publicado: (2022)

Assessment of ECG during hybrid comprehensive telerehabilitation in heart failure patients—Subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) randomized clinical trial
por: Orzechowski, Piotr, et al.
Publicado: (2021)

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
por: Morrow, David A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_30sgmfital3se6nb173vltt2em